Get Started

KLRA

NASD Kailera Therapeutics, Inc.
Nov 8, 2026 · 11:54 AM ET EOD Market Closed

$12.97 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.97, $0.29 below the day’s high of $13.26

YTD change
-50.12%
vs 20-day SMA
+5.42%
vs 200-day SMA
N/A

Price ranges

Previous day
$11.97 $13.26
open $12.29 close $12.97
+$0.68 (+5.53%)
Today
$11.97 $13.26
$12.97
Past week
$11.88 $13.41
from $13.41 now $12.97
-$0.44 (-3.28%)
Past month
$9.98 $13.83
from $10.00 now $12.97
+$2.97 (+29.70%)
This year
$9.76 $28.23
from $26.00 now $12.97
-$13.03 (-50.12%)

Price & Performance

-8.50 (-39.59%) / 6M

$8.94$14.08$19.22$24.36May 8Aug 10Nov 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 54.1% away from all-time highs of $28.23
  • KLRA is down 50% since the beginning of the year
  • KLRA is down 50% over the past 12 months
  • KLRA is up 30% over the past 1 month
  • 15% of all KLRA investors are betting against KLRA

KLRA reads very good: the 12-month move is -50.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.0888
Earnings momentum -48.4% Quarterly EPS growth
Quarterly change -48.4%

Valuation

P/E ratio N/A
Enterprise value $686.8M
Beta -0.30

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$901.5M
Debt$10.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.7B

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,354.00 -0.79%
JNJ Johnson & Johnson $276.22 +1.43%
ABBV AbbVie, Inc. $291.31 +1.07%
MRK Merck & Co., Inc. $146.73 -0.14%
RHHBY Roche Holding Ltd Sponsored ADR $59.37 -0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.